Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

April 30, 2015

Study Completion Date

March 31, 2018

Conditions
Gastroesophageal Reflux DiseaseHiatal Hernia
Interventions
DEVICE

TIF Transoral Fundoplication

A novel surgical technique that creates a gastric fundoplication and restores competency of the gastroesophageal valve now exists for patients who have limited anatomic defects (small hiatal hernia). This technique is performed transorally using the EsophyX device (EndoGastric Solutions, Inc. Redmond, WA, USA) recreates a gastric fundoplication at the gastroesophageal junction by creating a flap valve at the intersection of the stomach and the esophagus by deploying polypropylene SerosaFuse fasteners (EndoGastric Solutions)

OTHER

Sham placebo procedure

The Sham Procedure (control) will consist of an upper GI endoscopy that will be conducted under general anesthesia in an operating room. The surgical team will follow the same steps before, during, and after the sham procedure similar to the TIF procedure, except they will never insert the EsophyX device into the patient. The endoscope will be manipulated for 30-45 min as if the device were around it to simulate the effect of many rotations and manipulations on the esophagus.

Trial Locations (9)

20190

Reston Surgical Associates, Reston

43211

Ohio State University Hospital, Columbus

60611

Northwestern University, Chicago

77401

University of Texas, Health Science Center at Houston, Houston

80110

SurgOne PC, Englewood

90048

Cedars Sinai Medical Center, Los Angeles

97210

The Oregon Clinic, Portland

97239

Oregon Health and Science University, Portland

98195

University of Washington, Seattle

Sponsors
All Listed Sponsors
lead

EndoGastric Solutions

INDUSTRY

NCT01136980 - Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study | Biotech Hunter | Biotech Hunter